Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 5;21(21):8302.
doi: 10.3390/ijms21218302.

Alternatives to Insulin for the Regulation of Blood Sugar Levels in Type 2 Diabetes

Stephen C Bondy  1 , Meixia Wu  2 , Kedar N Prasad  3
Affiliations
Review

Alternatives to Insulin for the Regulation of Blood Sugar Levels in Type 2 Diabetes

Stephen C Bondy et al. Int J Mol Sci. .

Abstract

This short overview focuses on the causation and treatment of type 2 diabetes (T2D). Emphasis is given to the historical basis of understanding this disease and the background leading to emergence of the central role of insulin. The strengths of insulin administration in the treatment of diabetes are profound, but these need to be balanced against several serious shortcomings of its extended use. Some alternative approaches to T2D management are considered. Insulin is no longer considered as the first choice for type 2 diabetes, and an expanding range of new therapeutic possibilities is emerging. While these may lack the potency of insulin, at a minimum, they allow a major reduction in the intensity of insulin use. In view of the rising worldwide incidence of this disease, it is imperative to develop safe and inexpensive means of limiting its potential for impairment of normal functioning.

Keywords: diabetes; inflammation; insulin; insulin resistance diet; oxidative stress.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Connections among factors impacting on type 2 diabetes.
See this image and copyright information in PMC

References

    1. Karamanou M., Protogerou A., Tsoucalas G., Androutsos G., Poulakou-Rebelakou E. Milestones in the history of diabetes mellitus: The main contributors. World J. Diabetes. 2016;7:1–7. doi: 10.4239/wjd.v7.i1.1. - DOI - PMC - PubMed
    1. Stefan M., Zhang W., Concepcion E., Yi Z., Tomer Y. DNA methylation profiles in type 1 diabetes twins point to strong epigenetic effects on etiology. J. Autoimmun. 2014;50:33–37. doi: 10.1016/j.jaut.2013.10.001. - DOI - PMC - PubMed
    1. Chafe R., Aslanov R., Sarkar A., Gregory P., Comeau A., Newhook L.A. Association of type 1 diabetes and concentrations of drinking water components in Newfoundland and Labrador, Canada. BMJ Open Diabetes Res. Care. 2018;6:e000466. doi: 10.1136/bmjdrc-2017-000466. - DOI - PMC - PubMed
    1. Unsworth R., Wallace S., Oliver N.S., Yeung S., Kshirsagar A., Naidu H., Kwong R.M.W., Kumar P., Logan K.M. New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K. Diabetes Care. 2020:dc201551. doi: 10.2337/dc20-1551. - DOI - PubMed
    1. Yang J.-K., Lin S.-S., Ji X.-J., Guo L.-M. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010;47:193–199. doi: 10.1007/s00592-009-0109-4. - DOI - PMC - PubMed